Plans underway to speed up new biologicals license procedure

Published: 2006-09-25 06:57:00

Updated: 2006-09-25 06:57:00

The government is considering shortening the period of new biological products in the process of screening their safety and efficacy by introducing the so-called mid-term assessment systemas part of its plan to ensure earlier launching of promising items, according to the Korea Food and Drug Admi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK